A detailed history of Voya Investment Management LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 29,697 shares of VIR stock, worth $288,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,697
Previous 30,054 1.19%
Holding current value
$288,060
Previous $267,000 16.85%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.26 - $10.7 $2,591 - $3,819
-357 Reduced 1.19%
29,697 $222,000
Q2 2024

Dec 03, 2024

BUY
$7.63 - $12.66 $2,723 - $4,519
357 Added 1.2%
30,054 $267,000
Q2 2024

Aug 14, 2024

BUY
$7.63 - $12.66 $16,976 - $28,168
2,225 Added 8.0%
30,054 $267,000
Q1 2024

Dec 06, 2024

SELL
$8.6 - $11.9 $16,064 - $22,229
-1,868 Reduced 6.29%
27,829 $281,000
Q1 2024

May 15, 2024

SELL
$8.6 - $11.9 $52,829 - $73,101
-6,143 Reduced 18.08%
27,829 $281,000
Q4 2023

Feb 14, 2024

BUY
$7.76 - $10.29 $3,414 - $4,527
440 Added 1.31%
33,972 $341,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $24.62 $4,899 - $13,196
536 Added 1.62%
33,532 $314,000
Q2 2023

Aug 14, 2023

SELL
$23.2 - $27.29 $58,974 - $69,371
-2,542 Reduced 7.15%
32,996 $809,000
Q1 2023

May 15, 2023

SELL
$22.26 - $30.85 $48,972 - $67,870
-2,200 Reduced 5.83%
35,538 $826,000
Q4 2022

Feb 14, 2023

SELL
$19.96 - $28.22 $90,698 - $128,231
-4,544 Reduced 10.75%
37,738 $955,000
Q3 2022

Mar 03, 2023

BUY
$18.26 - $31.1 $82,973 - $141,318
4,544 Added 12.04%
42,282 $815,000
Q3 2022

Nov 14, 2022

SELL
$18.26 - $31.1 $71,816 - $122,316
-3,933 Reduced 8.51%
42,282 $815,000
Q2 2022

Aug 15, 2022

BUY
$19.08 - $26.7 $429,223 - $600,643
22,496 Added 94.84%
46,215 $1.18 Million
Q1 2022

May 16, 2022

BUY
$21.19 - $40.01 $12,650 - $23,885
597 Added 2.58%
23,719 $610,000
Q4 2021

Feb 14, 2022

SELL
$30.97 - $54.03 $8,392 - $14,642
-271 Reduced 1.16%
23,122 $968,000
Q3 2021

Nov 15, 2021

SELL
$34.9 - $54.54 $11,900 - $18,598
-341 Reduced 1.44%
23,393 $1.02 Million
Q2 2021

Aug 16, 2021

BUY
$38.75 - $51.0 $10,268 - $13,515
265 Added 1.13%
23,734 $1.12 Million
Q1 2021

May 17, 2021

BUY
$26.34 - $83.07 $4,293 - $13,540
163 Added 0.7%
23,469 $1.2 Million
Q4 2020

Feb 16, 2021

BUY
$25.51 - $43.38 $131,580 - $223,754
5,158 Added 28.42%
23,306 $624,000
Q3 2020

Nov 16, 2020

BUY
$28.28 - $53.6 $60,236 - $114,168
2,130 Added 13.3%
18,148 $623,000
Q2 2020

Aug 14, 2020

BUY
$27.89 - $47.86 $446,742 - $766,621
16,018 New
16,018 $656,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.29B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.